3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Venous Thromboembolism
1
Polycythemia Vera
1
Pancreatic Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lynch syndrome I (site-specific colonic cancer)
1
Liver Cirrhosis
1
Fibrosis
1
Endometrial Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Interventions
Carboplatin
3
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
selinexor
1
ponatinib
1
poly ICLC
1
pemigatinib
1
neratinib
1
donafenib
1
cobimetinib
1
ceritinib
1
cemiplimab
1
brigatinib
1
abemaciclib
1
Thymopentin
1
Taxes
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Radiation
1
Pluvicto
1
Platinum Compounds
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Nivolumab
1
Neck Dissection
1
NF protocol
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Carcinoma
×
Aspirin
×
Clear all
NCT07529262
2026-04-14
AspiRe HCC
Curtin University
Phase 3
Not yet recruiting
890 enrolled